Who is sponsoring NCT05954273?

NCT05954273 is sponsored by Versah.

What drugs are being tested in NCT05954273?

Interventions in NCT05954273: Osseodensification crestal sinsus graft.

What condition does NCT05954273 study?

NCT05954273 studies Sinus Floor Augmentation, Sinus Infection.

Is NCT05954273 still recruiting?

NCT05954273 is currently status unknown. Last updated 24 July 2023.

Last reviewed 2023-07-24 · How we verify

NCT05954273

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Maxillary Sinus Membrane Perforation Incidence During Osseodensification

Status unknown Last updated 24 July 2023

What this trial tests

trial testing Osseodensification crestal sinsus graft in Sinus Floor Augmentation in 500 participants. Status unknown.

Timeline

3 April 2023

Primary endpoint
31 July 2023

28 August 2023

Quick facts

Lead sponsor	Versah
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	500
Start date	3 April 2023
Primary completion	31 July 2023
Estimated completion	28 August 2023
Sites	1 location across United States

Drugs / interventions tested

Osseodensification crestal sinsus graft

Conditions studied

Sinus Floor Augmentation — all drugs for Sinus Floor Augmentation →
Sinus Infection — all drugs for Sinus Infection →

Sponsor

Versah

Who can join

Adults 21 to 90, any sex, with Sinus Floor Augmentation or Sinus Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Measure the incidence of the maxillary sinus membrane perforation during the Osseodensification crestal sinus grafting procedure.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Maxillary sinus membrane perforation rate utilizing osseodensification-mediated transcrestal sinus floor elevation: A multicenter clinical study.
Mazor Z, Gaspar J, Silva R, Pohl S, et al · · 2024 · cited 8× · PMID 39187444 · DOI 10.1111/cid.13368

Verify or expand the search:

Other recruiting trials for Sinus Floor Augmentation

Currently open trials in the same condition.

NCT07526337 — Digital Planning and Clinical Assessment of the Treated Atrophic Posterior Maxilla With a Sinus Lift Procedure: a Cross- · recruiting
NCT07526129 — Impact of Alveolar Ridge Preservation on the Potential Need for Sinus Floor Elevation: A 10-year Retrospective Radiograp · recruiting
NCT05315791 — Clinical Application Strategies of Maxillary Sinus Buccal Bony Window · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05954273 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Versah
Last refreshed: 24 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05954273.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing